Diagnostic, Clinical, and Therapeutic Aspects of Familial Hypercholesterolemia in Children

Seminars in Vascular Medicine

Volumn 4, Issue 1, 2004, Pages 51-57

  Ose, Leiv ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adolescents; Children; Diet; Drug treatment; Familial hypercholesterolemia

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; COLESTIPOL; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; PRAVASTATIN; RESIN; SIMVASTATIN;

ADOLESCENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CLINICAL FEATURE; DIET THERAPY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FAT INTAKE; FEMALE; GENE MUTATION; HEART DILATATION; HUMAN; MALE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RECEPTOR GENE; REVIEW; SIDE EFFECT; TREATMENT INDICATION;

ADOLESCENT; CHILD; CHILD WELFARE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II;

EID: 1642408237     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822986     Document Type: Review

References (43)

1. Kwiterovich PO. Identification and treatment of heterozygous familial Hypercholesterolemia in children and adolescents. Am J Cardiol 1993;72:30D-37D
2. Kwiterovich PO. Biochemical, clinical, epidemiological, genetic, and pathological data in the pediatric age group relevant to the cholesterol hypothesis. Pediatrics 1992;89:525-584
3. Academy of Pediatrics. National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:525-584
4. Wiegman A, Rodenburg J, De Jongh S, et al. Family history and cardiovascular risk in Familial Hypercholesterolemia: data in more than 1000 children. Circulation 2003;107:1473-1478
5. Tonstad S. Stratification of risk in children with familial hypercholesterolemia with focus on psychological issues. Nutr Metab Cardiovasc Dis 2001;11(Suppl 5):64-67
6. Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM. Relation of homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res 1996;40:47-52
7. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and controls. Arterioscler Thromb Vasc Biol 1996;16:984-991
8. Tonstad S, Refsum H, Ose L, Ueland PM. The C677T mutation in the methylene-tetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr 1998;132:365-368
9. Umans-Eckenhausen MAW, Sijbrands EJG, Kastelein JJP, Defesche JC. Low-Density Lipoprotein-receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002;106:3031-3036
10. Couture C, Brun LD, Szots F, et al. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1998;18:1007-1012
11. Tell GS, Mittelmark MB, Vellar OD. Cholesterol, high density lipoprotein cholesterol and triglycerides during puberty: the Oslo Youth study. Am J Epidemiol 1985;122:750-761
12. Setälä-Alto K, Viikarari J, Åkerblom HK, Kuusela V, Kontula K. DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood. J Lipid Res 1991;32:1477-1487
13. De Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJP, Stroes ES. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 2002;163:193-197
14. Tuzco EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001;103:2705-2710
15. Pathological Determinants of Atherosclerosis in Youth Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990;264:3018-3024
16. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001;104:2815-2819
17. Jarvisalo MS, Jartti L, Nanto-Salonen K, et al. Increased aortic intima-media thickens: a marker of preclinical atherosclerosis in high risk children. Circulation 2001;104:2943-2947
18. Wiegman A, Rodenburg J, Gort J, et al. B-mode ultrasound material wall thickness measurements in children proven heterozygous for familial hypercholesterolemia. Atherosclerosis 2002;3S:236-236
19. Poustie VJ, Rutherford P. Dietary treatment for familial hypercholesterolemia. Cochrane Database Syst Rev 2001;(2):CD001918. Review
20. Mabuchi H, Yagi K, Haraki T, Matsushita H, Inazu A, Kajinami K, Koizumi J. Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency. Ann N Y Acad Sci 1995;748:333-341
21. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149-1172
22. Jacques H, Laurin D, Moorjani S, et al. Influence of diets containing cow's milk or soy protein beverages on plasma lipids in children with familial hypercholesterolemia. J Am Coll Nutr 1992;11(Suppl):69S-73S
23. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res 1995;36:1807-1812
24. Amundsen AL, Ose L, Nenseter MS, Ntanios FY. Plant sterol ester-enriched spread lowers plasma total and LDL-cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr 2002;76:338-344
25. de Jongh S, Vissers MN, Rol P, Bakker HD, Kastelein JJP, Stroes ESG. Plant sterols lower LDL cholesterol without improving endothelial function in pre-pubertal children with familial hypercholesterolemia. J Inherit Metab Dis 2003;26:343-351
26. National Cholesterol Education Program. Report of the Expert Panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:525-584
27. Tonstad S, Knudtzon J, Sivertsen M, Refsum H, Ose L. Efficacy and safety of cholestyramine in pubertal a prepubertal children with familial hypercholesterolemia. J Pediatr 1996;129:42-39
28. Writing Group for the Dros Inf ServC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (Dros Inf ServC). JAMA 1995;273:1429-1435
29. Tonstad S, Sivertsen M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolemia. Arch Dis Child 1996;74:157-160
30. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 1997;130:266-273
31. Knapp HH, Schrott H, Ma P, et al. Efficacy and safety of combination simvastatin and colesevalam in patients with primary hypercholesterolemia. Am J Med 2001;110:352-360
32. De Jongh S, Stalenhoef AFH, Tuohy MB, Mercuri M, Bakker HD, Kastelein JJP. Efficacy and tolerability of simvastatin in children with familial hypercholesterolemia. Clinical Drug Investigation 2002;22:533-540
33. De Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial Hypercholesterolemia. Circulation 2002;106:2213-2237
34. McCrindle B, Ose L, Marais D. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia and/or severe hyperlipidemia: multicenter, randomized, placebo-controlled trial. J Pediatr 2003;143:74-80
35. Stein EA, Illingworth DR, Kwiterovich PO, et al. Efficacy and safety of lovastin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281:137-144
36. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin in children. Lancet 1992;339:1488
37. Knipscheer HC, Boelen CC, Kastelein JJP, et al. Short term efficacy and safety of pravastatin in 72 children with familial Hypercholesterolemia. Pediatr Res 1996;39:867-871
38. Lambert M, Lupien PJ, Cagne C, et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Pediatrics 1996;97:619-628
39. Stein EA, Illingworth DR, Kwiterovich PO, et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 1999;281:137-144
40. Newman TB, Browner WS, Hulley SB. The case against childhood cholesterol screening. JAMA 1990;264:3039-3043
41. Holzman NA. The great god cholesterol. Pediatrics 1991;87:943-945
42. Tonstad S, Novik TC, Vandvik IH. Psychosocial function during treatment for familial hypercholesterolemia. Pediatrics 1996;98:249-255
43. de Jongh S, Kerckhoffs MC, Grootenhuis MA, Bakker HD, Heymans HS, Last BF. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr 2003;92:1096-1101